echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > The guidance on medical supervision system has been reviewed and approved

    The guidance on medical supervision system has been reviewed and approved

    • Last Update: 2018-05-14
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Source: saibelan May 14, 2018 medical network may 14, May 11, according to Xinhua news agency, "the second meeting of the Central Committee for comprehensively deepening reform" was held The meeting deliberated and adopted a series of documents, including the guiding opinions on the reform and improvement of the comprehensive supervision system of the medical and health industry The meeting pointed out that the reform and improvement of the comprehensive supervision system of the medical and health industry is of great significance for safeguarding the health rights and interests of the people Here comes the core point: we should accurately grasp the laws and characteristics of the development of medical and health services, and change the concept, system and mode of supervision and management From the key supervision of public medical and health institutions to the industry wide supervision, from the focus on prior approval to the focus on the whole process after the event, from one-way supervision to comprehensive collaborative supervision, to improve the regulatory capacity and level ▍ every link, the integrated regulatory system, is coming Basically, the above is the core content of the document "guiding opinions on the reform and improvement of the comprehensive regulatory system of the medical and health industry" just reviewed and adopted This document has not yet been published, and the specific regulatory system plan is unknown But according to "from the key supervision of public medical and health institutions to the industry wide supervision, from the focus on prior approval to the focus on the whole process after the event, from one-way supervision to comprehensive collaborative supervision, to improve the regulatory capacity and level." It is likely that there will be a specific regulatory system centering on medical institutions, radiating the entire pharmaceutical industry, and introducing measures to integrate all aspects of production, sales and use This document should be released soon and we will meet with you.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.